Medical Devices · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Xtant Medical Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get XTNT alertsScott Neils is recorded as CFO at Xtant Medical Holdings, Inc. (XTNT). The proxy statement of Xtant Medical Holdings, Inc. reports total compensation of $939,369 for Scott Neils in fiscal 2025, including a base salary of $416,000. Disclosed compensation is on record for 4 fiscal years. Scott Neils has spoken on 14 earnings calls across 1 company, most recently for Xtant Medical Holdings, Inc. on August 11, 2026. Xtant Medical Holdings, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Xtant Medical Holdings, Inc. includes Sean Browne (CEO and Board Member), Sean E. Browne (CEO and Board Member), Stavros G. Vizirgianakis (Chairman) and 7 others.
“Total revenue for the second quarter of 2026 was $23 million, compared to $35.4 million for the second quarter of 2025, or $24.8 million for the second quarter of 2025, on a pro forma basis, excluding the revenue from the non-core products and businesses that we sold to Companion Spine and non-recurring license…”
“I'll start first with our financial results and then conclude by sharing some specific amounts related to our recent divestitures and license revenue for the benefit of looking ahead to 2026.”
“Total revenue for the third quarter of 2025 was $33.3 million compared to $27.9 million for the same period in 2024.”
“Total revenue for the second quarter of 2025 was $35.4 million, compared to $29.9 million for the same period in 2024.”
“Total revenue for the first quarter of 2025 was $32.9 million, compared to $27.9 million for the same period in 2024. The 18% increase is attributed primarily to year-over-year growth in our biologics product family, exclusive of the impact of $3.6 million of licensing revenue during the first quarter of 2025.”
Medical Devices · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Xtant Medical Holdings, Inc. (XTNT) | Chief Financial Officer | $416,000 | $939,369 |
| 2024 | Xtant Medical Holdings, Inc. (XTNT) | Chief Financial Officer | $411,692 | $883,507 |
| 2023 | Xtant Medical Holdings, Inc. (XTNT) | Chief Financial Officer | $400,000 | $937,853 |
| 2022 | Xtant Medical Holdings, Inc. (XTNT) | Chief Financial Officer | $366,977 | $766,533 |